Report: Merrimack Pharma to IPO next week
January 27th, 2012
Merrimack Pharmaceuticals, a privately held biotechnology company, plans to launch an IPO next week, raising up to $166.7 million, according to regulatory filings and IPO tracker Renaissance Capital. The Cambridge, Mass. company filed with the SEC to sell 16,666,667 shares of common stock at an estimated initial offering price of between $8 and $10. The company is also granting underwriters the option to purchase up to 2.5 million additional shares for 30 days. Merrimack, which was founded in 2000, plans to list on the Nasdaq under the symbol MACK…



